235 related articles for article (PubMed ID: 9684127)
21. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
22. [The value of determining occult blood in clinical practice].
Hesse R; Busse E
Z Gesamte Inn Med; 1981 Feb; 36(3):suppl 233-5. PubMed ID: 7222850
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas.
Nakama H; Zhang B; Kamijo N
Hepatogastroenterology; 2004; 51(59):1333-6. PubMed ID: 15362746
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp.
Nakama H; Fukazawa K
Hepatogastroenterology; 2002; 49(43):157-9. PubMed ID: 11941942
[TBL] [Abstract][Full Text] [Related]
25. Relationship between the fecal occult blood test and benign anal disorders.
Sasaki K; Kunimoto M; Hirata K
Hepatogastroenterology; 2001; 48(38):445-7. PubMed ID: 11379329
[TBL] [Abstract][Full Text] [Related]
26. [Screening for upper G-I tract cancer by gastroscopy in a 2,000 suspected population].
Wang GQ
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):201-3. PubMed ID: 2612334
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation.
Zaman A; Hapke R; Flora K; Rosen H; Benner K
Am J Gastroenterol; 1999 Apr; 94(4):895-9. PubMed ID: 10201453
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
Yamamoto M; Nakama H
Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and survival rate of elderly patients with colorectal cancer detected by immunochemical occult blood screening.
Zhang B; Fattah A; Nakama H
Hepatogastroenterology; 2000; 47(32):414-8. PubMed ID: 10791202
[TBL] [Abstract][Full Text] [Related]
30. Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer.
Nakama H; Zhang B
Dig Dis Sci; 2000 Nov; 45(11):2195-8. PubMed ID: 11215738
[TBL] [Abstract][Full Text] [Related]
31. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
[TBL] [Abstract][Full Text] [Related]
32. Bidirectional endoscopy in patients with fecal occult blood.
Velez JP; Schwesinger WH; Stauffer J; Gaskill HV; Kazantsev GB; Sirinek KR; Strodel WE
Surg Endosc; 2002 Jan; 16(1):117-20. PubMed ID: 11961620
[TBL] [Abstract][Full Text] [Related]
33. Inspection for gastric occult blood at regular intervals is the optimum program for the screening of esophageal-gastric cancer.
Qin D; Wang G; Zhang X; Zuo J; Yuan F; Li M; Geng C; Wang L; Jv C; Chen J
Ann Ital Chir; 1995; 66(1):41-4; discussion 45-6. PubMed ID: 7668481
[TBL] [Abstract][Full Text] [Related]
34. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
35. [Screening for colorectal cancer with an immunological fecal occult blood test].
Fernández JL; Gallegos M; Brochero A; Arévalo C; Piccioni H; Gutiérrez Galiana H
Acta Gastroenterol Latinoam; 1999; 29(2):73-8. PubMed ID: 10491719
[TBL] [Abstract][Full Text] [Related]
36. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
37. Upper gastrointestinal endoscopy: a review of 10,000 cases.
Taye M; Kassa E; Mengesha B; Gemechu T; Tsega E
Ethiop Med J; 2004 Apr; 42(2):97-107. PubMed ID: 16895026
[TBL] [Abstract][Full Text] [Related]
38. Upper digestive tract dyspepsia and early gastric cancer.
Bianchi A; Suñol J; Hidalgo LA; Diloy R; Castellví JM; Gorgas F; Soler T; Muns R; Gubern JM
Rev Esp Enferm Dig; 1998 Sep; 90(9):639-45. PubMed ID: 9780800
[TBL] [Abstract][Full Text] [Related]
39. Value of the history and stool occult blood test in selection of patients for upper endoscopy in Zimbabwe.
Xavier RJ; Stein CM; Kiire CF; Arrow J; Kitai I
East Afr Med J; 1992 May; 69(5):268-71. PubMed ID: 1644046
[TBL] [Abstract][Full Text] [Related]
40. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
